Hong Kong biopharmaceutical stocks strengthen, with Zaiding Pharmaceutical rising over 12%
我放心你带套猛
发表于 2024-10-18 11:41:24
224
0
0
On the morning of October 18th, Hong Kong biopharmaceutical stocks strengthened, with Zaiding Pharmaceutical rising over 12%, WuXi AppTec rising over 7%, Kangnuo and Nuocheng Jianhua rising over 6%, WuXi Biologics rising over 3%, and WuXi AppTec and Junshi Biologics rising over 2%.
CandyLake.com 系信息发布平台，仅提供信息存储空间服务。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
转播
猜你喜欢
- Novartis Pharmaceuticals rose over 150% in the US stock market before trading
- Pfizer plans to launch a drug platform directly targeting consumers
- NIO fell over 7%! Most Hong Kong listed cars weaken, Great Wall Motors: will not excessively participate in the 'price war'
- Pfizer launches drug sales platform directly targeting American patients
- Hong Kong auto stocks strengthened again in the afternoon, with NIO rising over 21%
- During the National Day holiday, Hong Kong stocks and Chinese concept stocks performed outstandingly
- Hong Kong auto stocks continue to weaken, with Ideal Auto falling more than 9%
- Hong Kong auto stocks receive market boost, Xiaopeng and Zero Run both rise by over 5%
- Pfizer plans to sell hospital drug division, company responds
- Jianxun Daily | Hengrui Pharmaceutical and IDEAYA signed an authorization agreement; Liu Zhongliang, the actual controller of Weikang Pharmaceutical, has been registered
